Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Tax Provisions (2022 - 2025)

Arcturus Therapeutics Holdings' Tax Provisions history spans 4 years, with the latest figure at -$4000.0 for Q4 2025.

  • For Q4 2025, Tax Provisions changed 0.0% year-over-year to -$4000.0; the TTM value through Jun 2025 reached -$200000.0, down 114.86%, while the annual FY2024 figure was -$4000.0, 100.22% down from the prior year.
  • Tax Provisions reached -$4000.0 in Q4 2025 per ARCT's latest filing, down from $4000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $893000.0 in Q3 2023 to a low of -$200000.0 in Q3 2024.
  • Average Tax Provisions over 4 years is $176545.5, with a median of $100000.0 recorded in 2022.
  • The largest YoY upside for Tax Provisions was 268.0% in 2024 against a maximum downside of 125.0% in 2024.
  • A 4-year view of Tax Provisions shows it stood at $100000.0 in 2022, then surged by 135.0% to $235000.0 in 2023, then plummeted by 101.7% to -$4000.0 in 2024, then changed by 0.0% to -$4000.0 in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Tax Provisions are -$4000.0 (Q4 2025), $4000.0 (Q2 2025), and -$4000.0 (Q4 2024).